β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension

Numerous studies have demonstrated that β(1)- and β(2)-adrenergic receptor gene (ADRB1 and ADRB2) variants influence cardiovascular risk and β-blocker responses in hypertension and heart failure. We evaluated the relationship between ADRB1 and ADRB2 haplotypes, cardiovascular risk (death, nonfatal m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pacanowski, MA, Gong, Y, Cooper-DeHoff, RM, Schork, NJ, Shriver, MD, Langaee, TY, Pepine, CJ, Johnson, JA
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2675574/
https://ncbi.nlm.nih.gov/pubmed/18615004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2008.139
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak